Predictive Factors Study
Predictive Factors Study
This is a long term study to evaluate common therapeutic algorithms and possible predictive
 parameters for Somatuline Autogel treatment in patients with Acromegaly.
Inclusion Criteria:

 -  Diagnosis of Acromegaly.

 -  Males and females aged 18 years and older.

 -  Signed informed consent (patient must give consent to the collection of retrospective
 data).

 -  Patients who have had surgery may enter the study 3 months post-surgery and evaluated
 for the duration of the study.

 -  With the intention to be treated with ATG (decision to prescribe ATG made prior to
 inclusion into the study) or already being treated with ATG.

 -  If already being treated with ATG:

 Previous ATG treatment maximum of 3 months. AND Minimum data available (demographic data,
 disease history including previous treatments, GH, IGF-1 levels at baseline and under
 treatment as applicable).

 -  Not receiving Dopamine Agonists or other medical therapy (Pegvisomant, or other
 somatostatin analogues) for the treatment or symptom control of acromegaly.

 Exclusion Criteria:

 -  The subject has had radiotherapy in the last 5 years.

 -  The subject has had surgery in the last 3 months.

 -  The subject has already been included in this study.

 -  Participation in an interventional trial, or receiving experimental drug.